Valley Wealth Managers’s GSK GSK Stock Holding History

Valley Wealth Managers’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$72.6K	Hold	1,508	–	–	﹤0.01%	210
2026 Q2	$79K	Hold	1,508	–	–	﹤0.01%	201
2026 Q1	$83.2K	Hold	1,508	–	–	0.01%	193
2025 Q4	$74K	Hold	1,508	–	–	﹤0.01%	202
2025 Q3	$65.1K	Hold	1,508	–	–	﹤0.01%	197
2025 Q2	$57.9K	Hold	1,508	–	–	﹤0.01%	194
2025 Q1	$58.4K	Hold	1,508	–	–	﹤0.01%	200
2024 Q4	$51K	Hold	1,508	–	–	﹤0.01%	212
2024 Q3	$61.6K	Buy	+1,508	New	+$61.7K	﹤0.01%	206
2016 Q4	–	Sell	-1,714	Closed	-$92K	–	265
2016 Q3	$92K	Hold	1,714	–	–	0.01%	129
2016 Q2	$93K	Sell	1,714 -2,286	-57%	-$120K	0.01%	126
2016 Q1	$203K	Buy	+4,000	New	+$199K	0.03%	109

Other funds holding GSK

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return

Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return

Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return

Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return

Bell Bank Fargo, North Dakota $2.66B AUM 18.07% 1-Year Est. Return

Keating Investment Counselors Delray Beach, Florida $382M AUM 16.71% 1-Year Est. Return

Robertson Stephens Wealth Management San Francisco, California $4.14B AUM 13.63% 1-Year Est. Return

Valley Wealth Managers's GSK Position: Q3 2026 in Review

Valley Wealth Managers held its GSK (GSK) position steady in Q3 2026 at 1,508 shares worth $72.6K. The position accounts for ﹤0.01% of the portfolio, ranked #210.

Valley Wealth Managers first reported a position in GSK in Q1 2016 and has held it in 12 quarters since. The position peaked at $203K in Q1 2016. 233 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

Valley Wealth Managers held 1,508 shares of GSK worth $72.6K as of Q3 2026.
Valley Wealth Managers left its GSK share count unchanged in Q3 2026.
GSK made up ﹤0.01% of Valley Wealth Managers's portfolio in Q3 2026, its #210 holding.
Valley Wealth Managers first reported a position in GSK in Q1 2016 and has held it in 12 quarters since.
Valley Wealth Managers's GSK position peaked at $203K in Q1 2016.
233 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on Valley Wealth Managers's 13F filing for Q3 2026, filed 9 Oct 2026.